We examined the role of melanocortin-4 receptors (MC4R) in proopiomelanocortin (Pomc) neurons in regulating metabolic and cardiovascular functions. Using Cre-loxP technology we selectively rescued MC4R in Pomc neurons of mice with whole body MC4R deficiency (MC4R-Pomc-Cre mice). Body weight, food intake and whole body oxygen consumption (VO2) were determined daily and blood pressure (BP), heart rate (HR) and body temperature were measured 24-hrs/day by telemetry. An intracerebroventricular (ICV) cannula was placed in the right lateral ventricle for ICV infusions. Littermate MC4R deficient (loxTB-MC4R) mice were used as controls. After control measurements, the MC4R antagonist (SHU-9119, 1 nmol/h) was infused ICV for 7 days. Compared to loxTB-MC4R mice, MC4R-Pomc-Cre mice were less obese (47±2 vs. 52±2 g) and had increased energy expenditure (2174±98 vs 1990±68 ml/kg/min), but food intake (4.4±0.2 vs 4.3±0.3 g/day), BP (112±1 vs 109±3 mmHg) and HR (557±9 vs 551±14 bpm) were similar between groups. Chronic SHU-9119 infusion increased food intake (4.2±0.2 to 6.1±0.5 g/day) and body weight (47±2 to 52±2 g) in MC4R-Pomc-Cre mice while no changes were observed in loxTB-MC4R mice. Chronic SHU-9119 infusion also increased BP and HR by 5±1 mmHg and 60±8 bpm in MC4R-Pomc-Cre mice without altering BP or HR in loxTB-MC4R mice. These results indicate that MC4R in Pomc neurons are important for regulation of energy balance. In contrast, while activation of MC4R in Pomc neurons facilitates the BP response to acute stress, our data do not support a major role of MC4R in Pomc neurons in regulating baseline BP and HR.
Introduction
The central nervous system (CNS) melanocortin pathway plays an important role in regulating appetite, energy expenditure, sympathetic nervous system (SNS) activity and blood pressure (BP). These effects are mediated mainly via activation of G proteincoupled melanocortin-4 receptors (MC4R) that are stimulated by α-melanocytestimulating hormone (α-MSH), a cleavage byproduct of proopiomelanocortin (Pomc) peptide in Pomc containing neurons (2, 3, 12, 13, 17, 20) . Pomc neurons are mainly located in the arcuate nucleus (ARC) of the hypothalamus and send projections to different areas of the brain including paraventricular nucleus (PVN), lateral hypothalamus (LH) and the dorsal-vagal complex (DVC) where these projections release α-MSH and activate MC4R receptors (13, 14, 20, 23, 24) . Other regions of the brain, including the nucleus of tractus solitarius (NTS, 10), also contain Pomc neurons, although the physiological role of Pomc neurons in the NTS is still largely unknown. A previous study by Balthasar et al. (1) showed that rescuing MC4R in the PVN attenuated 60% of weight gain found in mice with total body deletion of MC4R. These findings suggest that MC4R in other neuronal populations beside PVN are also important in body weight regulation by altering energy expenditure as well as food intake. However, the locations of these additional neuronal populations where MC4R activation controls metabolic and cardiovascular functions are still unclear.
The importance of the CNS melanocortin pathway in body weight homeostasis is demonstrated by the finding that humans and experimental animals with defective Pomc or MC4R signaling have early onset severe obesity associated with hyperphagia and reduced energy expenditure. The Pomc-MC4R axis may also be important in linking obesity with increased SNS activation and hypertension. For instance, mice with MC4R deficiency do not develop hypertension despite obesity and many features of metabolic syndrome including insulin resistance, hyperinsulinemia, hyperleptinemia, dyslipidemia, and increased visceral adiposity (22) . We have also shown that selective deletion of leptin receptors in Pomc neurons leads to mild obesity, hyperglycemia, hyperinsulinemia and completely abolishes leptin's ability to raise BP (7) . These results in mice are relevant to humans and are supported by the finding that the prevalence of hypertension is markedly reduced in obese humans with MC4R deficiency compared to control obese subjects (10, 11) .
Because Pomc neurons send projections to areas outside the ARC, it has generally been assumed that MC4R in neurons downstream from Pomc neurons, especially in the PVN and LH, mediate most of the effects on metabolic and cardiovascular functions.
However, MC4R may also be located on Pomc neurons and an in vitro study suggests that specific agonists of MC4R may depolarize Pomc neurons (18) . These observations are consistent with the possibility that MC4R located on Pomc neurons may act as an auto-excitatory and/or auto-potentiation mechanism that enhances Pomc activation leading to more efficient control of energy homeostasis and SNS activity. Based on our previous studies showing an important role for Pomc neurons in regulating BP and cardiovascular responses to acute stress (7) and the important role of MC4R in BP regulation (4, 5, 6, 8) , we hypothesized that MC4R located on Pomc neurons may mediate, at least in part, the physiological effects of the brain melanocortin system on cardiovascular and metabolic function. Therefore, if our hypothesis is correct, mice with MC4R present only in Pomc neurons should exhibit decreased food intake or increased energy expenditure, as well as increases in basal blood pressure; moreover, chronic inhibition of MC4R should reverse these expected effects. Since no previous studies, to our knowledge, have examined the physiologic role of MC4R on Pomc neurons in vivo, we generated mice where MC4R were present only in Pomc neurons and nowhere else in the body and compared their cardiovascular and metabolic phenotypes as well as their responses to chronic pharmacological antagonism of MC4R to those observed in mice with total body deletion of MC4R.
Materials and Methods
The experimental procedures and protocols of this study conform to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Mississippi Medical Center.
Male WT (n=5), LoxTB-MC4R (n=7) and MC4R-Pomc-Cre mice (n=6) were anesthetized with isoflurane (1.5%) and atropine sulfate (0.37 mg/kg) was administered to prevent excessive airways secretion. A telemetric pressure transmitter device (Model TA11PAC-10, Data Sciences International, MN) was implanted in the left carotid artery under sterile conditions as previously described (8, 22) . Mean arterial pressure (MAP) and heart rate (HR) were continuously measured 24 hrs/day and were derived from average MAP and HR measured by bursts of 10 seconds every 10 minutes using the software provided by the manufacturer (Dataquest 4.0).
Intracerebroventricular (ICV) cannulation
After telemetry probe implantation, a stainless steel cannula (33 gauge, 5 mm long) was implanted into the right lateral cerebral ventricle using the coordinates as previously described (16) . The guide cannula was anchored into place with 2 stainless steel machine screws, a plastic cap, and dental acrylic, and a stylet was inserted to seal the cannula until use. During stereotaxic manipulation, anesthesia was maintained with 1.5 -0.5% isofluorane. Several days after recovery from surgery, accuracy of the cannula placement was tested by measuring the dipsogenic response (immediate drinking of at least 1 ml of water in 5 minutes) to an ICV injection of 100 ng of angiotensin II.
After the surgical procedures, mice were housed individually in cages for determination of daily food consumption. Mice were provided normal sodium diet (0.5 mmol sodium/g food, Harlan Teklad) ad libitum. Mice were allowed to recover for 10-12 days before control measurements of food intake, body weight and plasma hormones were performed.
Experimental Protocol

Body weight and body composition analyses
Male WT (n=5), LoxTB-MC4R (n=7) and MC4R-Pomc-Cre (n=6) mice were individually housed and fed standard chow (Harlan Teklad, WI) starting at 6 weeks through 18 weeks of age. To examine the role of MC4R in Pomc neurons in regulating food consumption and body weight, food intake was measured daily and body weight twice a week. We also examined weekly changes in body composition using magnetic resonance imaging (EchoMRI-900TM, Echo Medical System, Houston, TX). MRI measurements were performed in conscious mice placed in a thin-walled plastic cylinder with a cylindrical plastic insert added to limit movement of the mice. Mice were briefly submitted to a low intensity electromagnetic field and fat mass, lean mass, free water and total water were measured. At sacrifice, the livers of LoxTB-MC4R and MC4R-PomcCre mice were removed and liver lean and fat mass content were measured using the tissue biopsy probe component of the EchoMRI scanner.
Oil Red-O Staining
To confirm the results obtained by tissue biopsy measurements of liver lean and fat mass content we also performed Oil Red-O staining in frozen liver sections (10 µm thick) of WT, LoxTB-MC4R and MC4R-Pomc-Cre mice. Sections were fixed in 10% buffered formalin for 5 min and stained for 10 min with 0.5% Oil Red-O in 60% isopropyl alcohol. The slides were washed several times in water and counterstained in Mayer's Haematoxylin for 30 sec. and mounted in aqueous mounting media. 
MC4R-GFP and Pomc immunohistochemistry
Glucose Tolerance Test
D-glucose (1.5 mg/kg of body weight) was administered intraperitonealy after a 6-hour fast in 22-week-old male LoxTB-MC4R (n=5) and MC4R-Pomc-Cre (n=5) mice. Blood samples were collected by tail snip and blood glucose was measured at 0, 15, 30, 60, 90
and 120 minutes after glucose injection using glucose strips (Reli On).
Western Blot for Uncoupling Protein-1 (UCP-1)
Interscapular brown adipose tissues (BAT) from LoxTB-MC4R (n=5) and MC4R-PomcCre (n=5) mice at 20 weeks of age were homogenized in lysis buffer (KPO4, pH 7. Emitter 4000, Bend, OR) implanted intraperitonealy 8 to 10 days prior to the beginning of the experiment. VO 2 was measured using a Zirconia oxygen sensor. VO 2 and body temperature were measured for 2 minutes at every 10-minute interval continuously 24-hours/day. After the mice were acclimatized to the new environment for 3 days, VO 2 and body temperature were measured for 5 consecutive days, then they were lightly anesthetized with isofluorane and a minipump was implanted in the scapular region and attached to the ICV cannula to deliver SHU-9119 (1 nmol/hr at 0.5 µl/hr) for 7 days. At the end of day 7 of SHU-9119 infusion, the tubing connecting the minipump to the ICV cannula was severed, and measurements were continued for an additional 5-day recovery period.
Acute MTII injection
Food intake and VO 2 were measured 12 and 24 hours after an intraperitoneal injection of MTII (400 µg, IP) or saline vehicle given between 5:15 and 5:30 PM in LoxTB-MC4R
(n=5) and MC4R-Pomc-Cre mice (n=5) at 22 weeks of age.
Acute Air-Jet Stress Test
To determine whether rescuing MC4R in Pomc neurons alters MAP and HR responses to an acute pressor stress, LoxTB-MC4R (n=6) and MC4R-Pomc-Cre (n=7) mice were placed in a special cage used for air-jet stress testing as previously described (7). After 
Chronic MC4R antagonism
After 10 days to recover from surgery, daily MAP, HR and food intake were recorded for infusion, the tubing connecting the minipump to the ICV cannula was severed, and measurements were continued for an additional 5-day recovery period.
Plasma Hormones and Glucose Measurements
Blood samples (100 µl) were collected via a tail snip after 6 hours of fasting (8:00 AM to 2:00 PM) during the control period (day 5), on the last day of SHU 9119 infusion (day 7) and at the end of the post-treatment period for measurements of plasma glucose, leptin and insulin concentrations. Plasma leptin and insulin concentrations were measured using ELISA (R&D Systems and Crystal Chem Inc., respectively), and plasma glucose concentrations were determined using the glucose oxidation method (Beckman glucose analyzer 2). The quantitative insulin-sensitivity check index (QUICKI) was also calculated from fasting insulin and glucose values. QUICKI= 1/[log (insulin in µU/mL) + log (fasting glucose in mg/dl).
Statistical Methods
The results are expressed as means ± SEM. The data were analyzed by paired t test or 1-way ANOVA with repeated measures followed by Dunnett's post hoc test for comparisons between control and experimental values within each group when appropriate. Comparisons between different groups were made by 2-way ANOVA followed by Bonferroni's post hoc test when appropriate. Statistical significance was accepted at a level of P<0.05.
Results
Selective rescue of MC4R in Pomc neurons reduces body weight, visceral adiposity and liver fat content, and improves glucose tolerance
Homozygous mice for the LoxTB-MC4R allele that also expressed Crerecombinase were used as MC4R-Pomc-Cre mice while littermate homozygous mice for the LoxTB-MC4R allele that did not express Cre-recombinase were used as controls (Fig. 1a) . To demonstrate co-localization between MC4R and Pomc neurons we used double-labeling immunofluorescence for GFP and Pomc protein immunoreactivity in MC4R-GFP mice. As expected, we observed positive MC4R staining in Pomc neurons (Fig. 1b) . Despite no differences in body length (nasal to anal distance, 10.6±0.1 versus 10.7±0.1 cm at 24 weeks of age) or average daily food intake from 8 to 18 weeks of age (Fig. 1c) MC4R-Pomc-Cre mice were less obese compared to LoxTB-MC4R mice (Fig.   1d ). Food intake was significantly higher in LoxTB-MC4R compared to MC4R-PomcCre mice only between 6 and 7 weeks of age. MC4R-Pomc-Cre mice exhibited higher lean and less fat body mass than LoxTB-MC4R mice as early as 6 weeks of age ( Fig.   1e,f) , smaller livers with less fat infiltration measured by magnetic resonance imaging (EchoMRI) and oil red-O staining ( Fig. 1g-j) , and reduced mesenteric and retroperitoneal fat content (Fig. 1k,l) . When compared to WT mice, however, MC4R-Pomc-Cre mice were still 67% heavier and consumed 22% more food (Fig. 1c-i) .
To test whether the reduced body weight and higher lean/fat mass ratio in MC4R-Pomc-Cre mice translated into better glucose handling we performed glucose tolerance tests (GTT) in both groups of mice at 20-22 weeks of age. MC4R-Pomc-Cre mice exhibited greater tolerance to a glucose load as reflected by a 40% smaller area under the blood glucose curve during the GTT (Fig. 1m,n) .
Selective rescue of MC4R in Pomc neurons is associated with increases in oxygen consumption (VO 2 ), body temperature and brown adipose tissue (BAT) uncoupling protein-1 (UCP1) expression
Since restoration of MC4R in Pomc neurons attenuated the obesity observed in LoxTB-MC4R mice by ~9% without altering food intake, we investigated whether the reduced body weight of MC4R-Pomc-Cre mice was accompanied by increased energy expenditure. We measured VO 2 and body temperature 24-hr/day for 5 consecutive days in 22 week-old mice and found that MC4R-Pomc-Cre mice had 10% greater VO 2 and 0.5 o C higher body temperature than control LoxTB-MC4R mice (Fig. 2a,b) . When compared to WT controls, MC4R-Pomc-Cre mice had similar body temperature but a 25% lower VO 2 ( Fig. 2a,b) . Interscapular BAT UCP1 protein content was also significantly higher in MC4R-Pomc-Cre compared to LoxTB-MC4R mice (Fig. 2c) .
These observations suggest that reduced body weight in MC4R-Pomc-Cre mice is likely due to increased energy expenditure. Thus, MC4R on Pomc neurons appear to play an important role in regulating basal energy expenditure while exerting little effect on basal control of appetite.
MC4R activation with Melanotan II (MTII) reduced food intake and increased VO 2 in MC4R-Pomc-Cre mice but not in LoxTB-MC4R mice
We examined whether exogenous activation of MC4R in Pomc neurons alters appetite and energy expenditure by administering 400 µg of MTII (single IP injection) to both groups just before lights out (6:00 pm) and measured food intake and VO 2 ml/kg/min) (Fig. 2d,e) . These results suggest that although baseline endogenous activation of MC4R in Pomc neurons plays a more important role in regulating basal energy expenditure than appetite, acute pharmacological activation of MC4R in these neurons can also suppress food intake in addition to increasing VO 2 .
Rescuing MC4R in Pomc neurons augments the cardiovascular response to acute stress without altering baseline blood pressure (BP) or heart rate (HR)
We have previously shown that brain MC4R play an important role in regulating BP and HR, and that they are required for obesity to be associated with increased sympathetic activation and hypertension (8, 22) . However, the brain regions where MC4R
contribute to the regulation of cardiovascular function are still largely unknown. To test the hypothesis that MC4R on Pomc neurons are important for the regulation of cardiovascular function, we measured BP and HR 24-hr/day using telemetry under normal conditions and during an acute air-jet stress test. We observed that although baseline BP (109±3 vs 112±1 mmHg) and HR (551±14 vs 557±9 bpm) were not different between LoxTB-MC4R and MC4R-Pomc-Cre mice (Fig. 3a,b) , the response to acute airjet stress in MC4R-Pomc-Cre mice was more pronounced than observed in LoxTB-MC4R control mice. For instance, we noticed a 55% and 40% greater rise in BP and HR in MC4R-Pomc-Cre mice during the 5-minute air-jet stress period ( Fig. 3c-f) . Moreover, BP and HR quickly returned to baseline values in control LoxTB-MC4R mice during the 30-minute recovery period post air-jet stress test, whereas in MC4R-Pomc-Cre mice BP and HR remained elevated (Fig. 3c-f) . These results indicate that MC4R in Pomc neurons may also modulate cardiovascular responses to acute stress.
Chronic central MC4R antagonism increased food intake, body weight and fasting plasma glucose levels in MC4R-Pomc-Cre mice but not in loxTB-MC4R mice
To examine whether chronic blockade of MC4R in mice with selective rescue of MC4R in Pomc neurons would result in hyperphagia and weight gain as we have observed in rats and lean wild type animals (4,5,6), we continuously infused SHU-9119
(1 nmol/hr) directly into the brain lateral ventricle for 7 days using osmotic minipumps connected to the ICV cannula. Chronic antagonism of MC4R increased food intake in MC4R-Pomc-Cre mice by approximately 60% over the 7-day treatment period (Fig. 4b) which resulted in a cumulative net food intake of almost 11 g (the sum of the daily difference in food intake during treatment compared to the average daily food intake during baseline period, Fig. 4c ). This increase in food intake caused significant weight gain in MC4R-Pomc-Cre mice which eliminated the initial difference in body weight between MC4R-Pomc-Cre and LoxTB-MC4R mice (Fig. 4a) . Chronic SHU-9119 infusion in LoxTB-MC4R mice produced no effect on food intake or body weight ( Fig.   4a-c) , indicating that the chronic effects of SHU-9119 on appetite are due mainly to antagonism of MC4R and not to a nonspecific effect of SHU-9119 or blockade of MC3R.
In WT mice, chronic MC4R antagonism increased food intake by ~27% leading to a cumulative net food intake of almost 7 g (Fig. 4a-c ) and significant weight gain (8.5%, Fig. 4a ). However, baseline fasting plasma glucose and insulin levels were significantly lower in MC4R-Pomc-Cre mice compared to LoxTB-MC4R control mice (Fig. 4d,e) ,
suggesting that rescue of MC4R in Pomc neurons improved insulin sensitivity as evidenced by an almost 50% reduction in plasma insulin levels while blood glucose levels were also reduced by approximately 20%. Moreover, chronic MC4R antagonism raised fasting glucose levels in MC4R-Pomc-Cre mice so that they were no longer different compared to LoxTB-MC4R mice while insulin levels remained unchanged, indicating that MC4R blockade impaired insulin sensitivity in MC4R-Pomc-Cre mice (Fig. 4d,e) . We further examined insulin sensitivity by calculating the QUICKI index and found that MC4R-Pomc-Cre had ~10% higher insulin sensitivity (0.253±0.006 vs 0.233±0.007) compared to LoxTB-MC4R mice. These observations suggest that MC4R
in Pomc neurons also contribute to the CNS control of glucose homeostasis. Baseline leptin levels were not different between groups and did not change during SHU-9119 infusion (Fig. 4f) .
We also tested whether SHU-9119 would reduce energy expenditure and body temperature in MC4R-Pomc-Cre mice. However, SHU-9119 ICV infusion did not alter VO 2 or body temperature in both groups (Fig. 4g,h ). In fact, SHU-9119 tended to increase VO 2 in MC4R-Pomc-Cre mice. This small increase in VO 2 may have been caused, in part, by increased food intake and rapid weight gain during SHU-9119 treatment. At the end of the experiment, the animals were killed and the brains removed and sectioned to confirm the placement of the cannula into the right lateral ventricle (Fig.   4i ).
Chronic ICV SHU-9119 infusion raised BP and HR in MC4R-Pomc-Cre mice
We previously demonstrated that MC4R provide a key link between obesity, increased SNS activity and hypertension (8, 22 ). Since we observed augmented BP and HR responses to stress in MC4R-Pomc-Cre mice we further hypothesized that SHU-9119
would reduce BP and HR in these mice. Surprisingly, blockade of MC4R raised BP and HR in MC4R-Pomc-Cre mice whereas no changes were observed in LoxTB-MC4R control mice (Fig. 5a-d) . In WT mice, SHU-9119 infusion reduced MAP and HR by -5 mmHg and -38 bpm, respectively. These data are consistent with our previous studies showing that chronic CNS MC4R inhibition reduces BP and HR despite increasing food intake and promoting weight gain (4,5).
Discussion
Our studies indicate that MC4R on Pomc neurons contribute to the regulation of body weight, body composition and energy expenditure. In addition, our observations indicate that MC4R on Pomc neurons modulate the cardiovascular responses to acute stress, but do not support a major role of MC4R in Pomc neurons in regulating baseline BP and HR. We also found other important effects of restoring MC4R function in Pomc neurons including improved glucose handling as evidenced by reductions in baseline circulating levels of insulin and glucose, and greater tolerance to a glucose load when compared to control MC4R deficient LoxTB-MC4R mice.
Control of Metabolic Functions by MC4R on POMC Neurons
It has generally been assumed that MC4R on second order neurons, especially However, the locations of neuronal populations where MC4R activation controls metabolic and cardiovascular functions are unclear.
Our current study suggests that Pomc neurons may be another site where MC4R
activation plays an important role in regulation of energy balance and cardiovascular function. Reactivation of MC4R only in Pomc neurons significantly attenuated hyperphagia and obesity as early 6-7 weeks of age in LoxTB-MC4R mice with total body deficiency of MC4R, an effect that could have important effects on body weight later in life. After 9-10 weeks of age we did not observe significant differences in food intake in
LoxTB-MC4R and MC4R-Pomc-Cre mice. However, reduced body weight, decreased total fat mass, improved glucose tolerance, and decreased liver fat were observed in 18-20 week old mice with MC4R reactivated only in Pomc neurons, compared to LoxTB-MC4R mice, despite no differences in food intake. At 18 weeks of age, mice with reactivation of MC4R also had increases in VO 2 , body temperature and uncoupling protein 1 (UCP 1), compared to mice with total body MC4R deficiency, suggesting that their reduced body weight was maintained mainly by increased metabolic rate. However, we cannot rule out the possibility that the small difference in body weight between groups may have contributed to the improved metabolic phenotype of MC4R-Pomc-Cre mice.
The potential importance of MC4R on Pomc neurons for controlling metabolic and cardiovascular function had not, to our knowledge, been previously reported. In vitro studies indicate that specific agonists of MC4R depolarize Pomc neurons whereas MC4R
antagonists hyperpolarize these neurons (18) , consistent with the possibility that MC4R located on Pomc neurons may act as an auto-excitatory and/or as an auto-potentiation mechanism that enhances Pomc neuron activation (Fig. 6) . To our knowledge, the results of the current study provide the first in vivo evidence that MC4R on Pomc neurons contribute importantly to several metabolic functions, including regulation of body weight and body composition, as well as BP and HR responses to acute stress.
Previous studies have shown that activation of MC4R in the CNS increases sympathetic activation to BAT and promotes thermogenesis (9, 19) . Here we showed that baseline VO 2 and MTII-stimulated increases in VO 2 were higher in MC4R-Pomc-Cre than in LoxTB-MC4R mice, which suggests that MC4R on Pomc neurons may be important in regulating SNS activity to BAT and thermogenesis. However, additional studies are needed to directly test this hypothesis.
Increased tolerance to acute an glucose load and reduced fasting plasma insulin and glucose levels observed in MC4R-Pomc-Cre mice may be explained, at least in part, by the combination of greater lean mass and reduced liver lipid infiltration in these mice.
Therefore, our observations provide evidence for an important role of MC4R on Pomc neurons in glucose homeostasis and preventing lipid deposition in non-adipose tissue.
Although rescue of MC4R in Pomc neurons did not substantially alter baseline food intake after 8-10 weeks of age, chronic central blockade of MC4R with SHU-9119 led to a 60-70% increase in food intake in MC4R-Pomc-Cre mice while not changing appetite in LoxTB-MC4R mice. In addition, blockade of MC4R receptors in lean WT mice significantly increased food intake and body weight, although less than in MC4R-PomcCre mice. A likely explanation for the enhanced effects of MC4R blockade on food intake and body weight in MC4R-Pomc-Cre mice is that they exhibit increased sensitivity to MC4R antagonism or an attenuated response by compensatory factors that restrain hyperphagia caused by MC4R antagonism. These possibilities, however, are only speculative and whether MC4R-Pomc-Cre mice exhibit impaired modulation of orexigenic/anorexigenic factors in response to chronic MC4R blockade is still unknown.
These observations lead us to speculate that despite not playing a major role in normal regulation of appetite in adult mice, MC4R on Pomc neurons may be important for tonic CNS melanocortin system regulation by other neurons that control food intake.
Therefore, when MC4R signaling in Pomc neurons is removed this may facilitate activation of orexigenic neurons and/or inhibition of anorexigenic neurons leading to marked increases in food intake. Further studies are necessary to address this hypothesis.
Control of Blood Pressure by MC4R on POMC Neurons
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